Impaired ventricular filling limits cardiac reserve during submaximal exercise in people with type 2 diabetes
Authors (first, second and last of 6)
Volume 16, issue 1, December 2017
160 articles in this issue
-
-
Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan
Authors (first, second and last of 10)
-
Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)
Authors (first, second and last of 4)
-
Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data
Authors (first, second and last of 7)
-
Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology
Authors (first, second and last of 11)
-
Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection
Authors (first, second and last of 5)
-
DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
Authors (first, second and last of 8)
-
Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study
Authors (first, second and last of 10)
-
Type 2 diabetes mellitus is associated with a lower fibrous cap thickness but has no impact on calcification morphology: an intracoronary optical coherence tomography study
Authors (first, second and last of 6)
-
Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%
Authors (first, second and last of 17)
-
Correction to: Updates on cardiovascular outcome trials in diabetes
Authors (first, second and last of 5)
-
-
Effects of hypoglycemia on myocardial susceptibility to ischemia–reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes
Authors (first, second and last of 6)
-
Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels
Authors (first, second and last of 11)
-
RETRACTED ARTICLE: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
Authors (first, second and last of 7)
-
Impact of overweight on left ventricular function in type 2 diabetes mellitus
Authors (first, second and last of 17)
-
-
Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis
Authors (first, second and last of 9)
-
Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy
Authors (first, second and last of 15)
-
Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains
Authors (first, second and last of 5)
-
Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms
Authors (first, second and last of 13)
-
Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies
Authors (first, second and last of 12)
-
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study
Authors (first, second and last of 7)
-
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)
Authors (first, second and last of 13)
-
-
Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
Authors (first, second and last of 9)
-
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Authors (first, second and last of 5)
-
Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease
Authors (first, second and last of 13)
-
The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation
Authors (first, second and last of 5)
-
Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus
Authors (first, second and last of 11)
-
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial
Authors (first, second and last of 5)
-
-
-
Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients
Authors (first, second and last of 9)
-
Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014)
Authors (first, second and last of 6)
-
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)
Authors (first, second and last of 15)
-
-
Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study
Authors (first, second and last of 6)
-
The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis
Authors (first, second and last of 8)
-
High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes
Authors (first, second and last of 5)
-
Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes
Authors (first, second and last of 5)
-
NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study
Authors (first, second and last of 10)
-
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance
Authors (first, second and last of 8)
-
Erratum to: Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study
Authors (first, second and last of 13)
-
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
Authors (first, second and last of 10)
-
Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition
Authors (first, second and last of 12)
-
The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control
Authors (first, second and last of 16)
-
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Authors (first, second and last of 7)
-
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus
Authors (first, second and last of 9)
-
Association between carotid plaque characteristics and acute cerebral infarction determined by MRI in patients with type 2 diabetes mellitus
Authors (first, second and last of 9)
